Terry Opgenorth, PhD
Terry joined CSU Ventures in 2007. During his tenure with the organization, Terry served as the Vice President for CSU Ventures and as the Executive Director for LAUNCHPAD. Recently, Terry shifted to become our first Executive-in-Residence, lending his considerable expertise to facilitating startup company success as a mentor and resource.
Prior to joining the technology transfer unit, Terry spent 20 years with Abbott Laboratories (now AbbVie) retiring as Vice President of Metabolic Disease, Antiviral and Target-Lead Discovery Research for the Global Pharmaceutical Division. He has also been President/CEO of Vidasym, and is a Co-Founder and CSO of VetDC. Terry serves as a Director on KromaTiD, VetDC, and UNeMed Boards. He previously served as Board Director for Colorado Institute for Drug, Device, and Diagnostic Development (CID4), Colorado Bioscience Association, and Keystone Symposia. Dr. Opgenorth holds a BA from Calvin College and MS and PhD degrees from University of Illinois Urbana-Champaign.